PharmiWeb

Study Shows CLn BodyWash Helps People With Hidradenitis Suppurativa (HS) Improve Comfort and Confidence

Clinical Study Led by HS Connect Demonstrates Significant Reduction in HS Symptoms and Improved Quality of Life With Daily ...
PharmiWeb

Ferrer Completes Recruitment of 220 Patients for the PROSPER Study, a Phase II Clinical Trial in Progressive Supranuclear Palsy (PSP), Two Months Ahead of Schedule

This is a randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy, safety, and ...
PharmiWeb

Satellos Announces First Adult Patient Dosed in LT-001, an Open-Label, Long-Term Follow-Up Study of SAT-3247 in Duchenne Muscular Dystrophy

First returning adult patient from Phase 1b study recently dosed; additional returning patients being scheduled11-month open-label study will evaluate functional outcomes, safety, muscle composition ...
PharmiWeb

Newleos Therapeutics Appoints Timothy Noyes as President and Chief Executive Officer

Newleos Therapeutics, Inc., a clinical-stage biotechnology company developing innovative treatments for neuropsychiatric disorders, today announced the appointment of Timothy Noyes as President and ...
PharmiWeb

Systematic Review of 15 Studies Focused on Epidemiology and Antimicrobial Resistance of Pneumococcal Serotypes Covered by CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine ...

Findings presented at IDWeek 2025 underscore the importance of considering serotypes that disproportionately impact adults in the U.S. and show greater resistance to commonly prescribed ...
PharmiWeb

Only 27% of European Hospitals Achieve Full Patient Data Exchange Across Borders Despite EU Interoperability Mandates

Black Book survey reveals just 1 in 4 hospitals can fully exchange patient data across national boundaries in Q4 2025 VIENNA, ...
PharmiWeb

China’s Pharmaceutical Revolution Goes Global: From $45B Deals to a New Era of Innovation

Challenges and New Momentumchina’s pharmaceutical innovation goes global challenges and new momentumIn the first five months ...
PharmiWeb

Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings

The investment enhances German facility to deliver more flexible and scalable drug delivery solutionsPIOMBINO DESE, Italy--(BUSINESS WIRE)--Stevanato Group S.p.A. (NYSE: STVN), a leading global ...
PharmiWeb

IFF and BASF Announce Strategic Collaboration to Drive Next-Generation Enzyme and Polymer Innovation

IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients, health and biosciences — announced a strategic ...
PharmiWeb

NDT Pharmaceuticals Showcases Strategic Value of Good Salt(TM) Life Acquisition with Expanded Relationship with Norwegian Cruise Line

ATHENS, GEORGIA / ACCESS Newswire / October 21, 2025 / NDT Pharmaceuticals Inc. (OTC PINK:NDTP), a company focused on advancing innovative consumer health and wellness solutions, today announced a ...
PharmiWeb

Clean Jeju Green Tea Cooperative ‘Sumang’ Accelerates R&D Efforts to Develop Functional Biomaterials from Jeju’s Natural Resources

Clean Jeju Green Tea Cooperative ‘Sumang’, a leading processor of agricultural, marine, and herbal materials from Jeju Island, announced plans to expands its research and development activities of ...
PharmiWeb

Atom Therapeutics to Present Positive Data from Clinical Trials of Its Lead Novel Oral Drugs for Chronic Gout and Acute Gout Flares at ACR Convergence 2025

Results of a Phase 2a dose escalating study of lingdolinurad (ABP-671) for chronic gout, which enrolled patients with mild to moderate renal impairment, showed the URAT1 inhibitor lowered serum uric ...